ArticleInternational journal of clinical and experimental pathology2018

Knockdown of SALL4 overcomes cisplatin-resistance through AKT/mTOR signaling in lung cancer cells.

Gang Jiang et al.PubMed ↗Full text ↗

No numbers read from the abstract.